Clinical Trial Update: Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting safety findings for donepezil in patients with vascular dementia, with the study status indicating completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Aricept (Donepezil)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Dementia Associated With Cerebrovascular Disease | Phase 3 | Status: COMPLETED